Midterm results with thoracic endovascular aortic repair for chronic type B aortic dissection with associated aneurysm.
OBJECTIVE
Thoracic endovascular aortic repair for chronic type B aortic dissection with associated descending thoracic aneurysm remains controversial. Concerns include potential ischemic complications due to branch vessel origin from the chronic false lumen and continued retrograde false lumen/aneurysm sac pressurization via fenestrations distal to implanted endografts. The present study examines midterm results with thoracic endovascular aortic repair for chronic (>2 weeks) type B aortic dissection with associated aneurysm to better understand the potential role of thoracic endovascular aortic repair for this condition.


METHODS
Between March 2005 and December 2009, 51 thoracic endovascular aortic repair procedures were performed at a single institution for management of chronic type B dissection. The indication for thoracic endovascular aortic repair was aneurysm in all cases. A subset of 7 patients (14%) underwent placement of the EndoSure wireless pressure measurement system (CardioMEMS, Inc, Atlanta, Ga) in the false lumen adjacent to the primary tear for monitoring aneurysm sac/false lumen pulse pressure after thoracic endovascular aortic repair.


RESULTS
Mean patient age was 57±12 years (range, 30-82 years); 14 patients (28%) were female. Mean aortic diameter was 6.2±1.4 cm. There were no in-hospital/30-day deaths, strokes, or permanent paraplegia/paresis. There were no complications related to compromise of downstream branch vessels arising from the false lumen. Two patients (3.9%) who had preexisting ascending aortic dilation had retrograde acute type A aortic dissection; both were repaired successfully. Median postoperative length of stay was 4 days. Mean follow-up is 27.0±16.5 months (range, 2-60 months). Actuarial overall survival is 77.7% at 60 months with an actuarial aorta-specific survival of 98% over this same time period. Actuarial freedom from reintervention is 77.3% at 60 months. All patients with the EndoSure wireless pressure measurement system exhibited a decrease in aneurysm sac/false lumen pulse pressure indicating a depressurized false lumen. The aneurysm sac/false lumen pulse pressure ratio decreased from 52%±27% at the predischarge measurement to 14%±5% at the latest follow-up reading (P=.029).


CONCLUSIONS
Thoracic endovascular aortic repair for chronic type B dissection with associated aneurysm is safe and effective at midterm follow-up. Aneurysm sac/false lumen pulse pressure measurements demonstrate a significant reduction in false lumen endotension, thus ruling out clinically significant persistent retrograde false lumen perfusion and provide proof of concept for a thoracic endovascular aortic repair-based approach. Longer-term follow-up is needed to determine the durability of thoracic endovascular aortic repair for this aortic pathology.
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Cyrus J
CJ
Parsa
Judson B
JB
Williams
Syamal D
SD
Bhattacharya
Walter G
WG
Wolfe
Mani A
MA
Daneshmand
Richard L
RL
McCann
G Chad
GC
Hughes
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000784:Aortic Dissection / Q000000981:diagnostic imaging / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D017545:Aortic Aneurysm, Thoracic / Q000000981:diagnostic imaging / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D001027:Aortography / Q000379:methods; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation / Q000401:mortality; D002908:Chronic Disease; D057510:Endovascular Procedures / Q000009:adverse effects / Q000295:instrumentation / Q000401:mortality; D005260:Female; D006439:Hemodynamics; D006801:Humans; D053208:Kaplan-Meier Estimate; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009657:North Carolina; D012086:Reoperation; D012189:Retrospective Studies; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014160:Transducers, Pressure; D016896:Treatment Outcome
Ann Thorac Surg. 2008 Nov;86(5):1707-12
19049790
J Vasc Surg. 2006 Feb;43 Suppl A:94A-99A
16473180
Semin Thorac Cardiovasc Surg. 2009 Winter;21(4):355-62
20226350
Ann Thorac Surg. 2010 May;89(5):1458-66
20417761
Ann Thorac Surg. 2008 Jan;85(1 Suppl):S1-41
18083364
Ann Thorac Surg. 2008 Nov;86(5):1530-7; discussion 1537-8
19049744
J Card Surg. 2010 Mar;25(2):223-4
20492031
J Endovasc Ther. 2009 Feb;16(1):60-70
19281290
J Clin Neurophysiol. 2007 Aug;24(4):328-35
17938601
Semin Roentgenol. 2009 Jan;44(1):29-51
19064070
Circulation. 2006 Jul 4;114(1 Suppl):I357-64
16820600
J Vasc Surg. 2008 Jun;47(6):1188-94
18440180
Ann Thorac Surg. 2010 Feb;89(2):446-52
20103319
Ann Thorac Surg. 2002 Nov;74(5):S1833-5; discussion S1857-63
12440675
Circulation. 2006 Nov 21;114(21):2226-31
17101856
J Heart Lung Transplant. 2009 Sep;28(9):958-63
19716050
JAMA. 1990 Nov 21;264(19):2537-41
2232021
Ann Thorac Surg. 2010 Jan;89(1):97-102; discussion 102-4
20103214
J Vasc Surg. 2002 May;35(5):1048-60
12021727